← United States · Coverage record
US · SEC FORM 4
Vaxcyte, Inc.
PCVX · Nasdaq · CIK 0001649094 · Healthcare · Biotechnology
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
78 Form 4 transaction lines observed in the same window
42 sales · 36 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
—
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2020-06-16 · BONDERMAN DAVID; COULTER JAMES G; TPG Group Holdings (SBS) Advisors, Inc..
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 17,290,712
- Previous report
- 16,132,520
- Avg daily volume
- 1,517,422
- Days to cover
- 11.4
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2020-06-16 | EMSTER KURT VON | Purchase (P) | Common Stock, $0.001 par value per share | 12,500 | USD 16.00 | USD 200,000 | SEC filing ↗ |
| 2020-06-16 | BONDERMAN DAVID; COULTER JAMES G; TPG Group Holdings (SBS) Advisors, Inc. | Purchase (P) | Common Stock | 937,500 | USD 16.00 | USD 15,000,000 | SEC filing ↗ |
| 2020-06-16 | Hopfner Robert Lorne | Purchase (P) | Common Stock | 93,000 | USD 16.00 | USD 1,488,000 | SEC filing ↗ |
| 2020-06-16 | Heron Patrick J | Purchase (P) | Common Stock | 250,000 | USD 16.00 | USD 4,000,000 | SEC filing ↗ |
Form 4 evidence
118 transaction lines in the latest 365-day window; 929 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Wassil Jim | Sale (S) | Common Stock | 18,000 | USD 86.74 | USD 1,561,320 | SEC filing ↗ |
| 2026-10-05 | Wassil Jim | Option exercise / conversion (M) | Common Stock | 18,000 | USD 5.35 | USD 96,300 | SEC filing ↗ |
| 2026-10-05 | Cowan Elvia | Sale (S) | Common Stock | 19,000 | USD 86.74 | USD 1,648,060 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Wassil Jim | Sale (S) | Common Stock | 18,000 | USD 86.74 | USD 1,561,320 | SEC filing ↗ |
| 2026-10-05 | Wassil Jim | Option exercise / conversion (M) | Common Stock | 18,000 | USD 5.35 | USD 96,300 | SEC filing ↗ |
| 2026-10-05 | Cowan Elvia | Sale (S) | Common Stock | 19,000 | USD 86.74 | USD 1,648,060 | SEC filing ↗ |
| 2026-10-05 | Cowan Elvia | Option exercise / conversion (M) | Common Stock | 19,000 | USD 25.92 | USD 492,480 | SEC filing ↗ |
| 2026-10-01 | Wassil Jim | Sale (S) | Common Stock | 2,250 | USD 56.67 | USD 127,513 | SEC filing ↗ |
| 2026-10-01 | Wassil Jim | Option exercise / conversion (M) | Common Stock | 2,250 | USD 5.35 | USD 12,038 | SEC filing ↗ |
| 2026-09-09 | Wassil Jim | Sale (S) | Common Stock | 1,334 | USD 59.52 | USD 79,400 | SEC filing ↗ |
| 2026-09-08 | Wassil Jim | Tax withholding (F) | Common Stock | 5,459 | USD 60.36 | USD 329,505 | SEC filing ↗ |
| 2026-09-08 | PICKERING GRANT | Tax withholding (F) | Common Stock | 17,056 | USD 60.36 | USD 1,029,500 | SEC filing ↗ |
| 2026-09-08 | GUGGENHIME ANDREW | Tax withholding (F) | Common Stock | 7,155 | USD 60.36 | USD 431,876 | SEC filing ↗ |
| 2026-09-08 | Dhaliwal Harpreet S. | Tax withholding (F) | Common Stock | 7,651 | USD 60.36 | USD 461,814 | SEC filing ↗ |
| 2026-09-08 | Cowan Elvia | Tax withholding (F) | Common Stock | 1,327 | USD 60.36 | USD 80,098 | SEC filing ↗ |
| 2026-09-04 | Wassil Jim | Sale (S) | Common Stock | 1,381 | USD 61.16 | USD 84,462 | SEC filing ↗ |
| 2026-09-04 | Jodar Luis | Award / grant (A) | Common Stock | 52,632 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-09-02 | Wassil Jim | Tax withholding (F) | Common Stock | 1,432 | USD 61.58 | USD 88,183 | SEC filing ↗ |
| 2026-09-02 | PICKERING GRANT | Tax withholding (F) | Common Stock | 3,427 | USD 61.58 | USD 211,035 | SEC filing ↗ |
| 2026-09-02 | GUGGENHIME ANDREW | Tax withholding (F) | Common Stock | 1,432 | USD 61.58 | USD 88,183 | SEC filing ↗ |
| 2026-09-02 | Dhaliwal Harpreet S. | Tax withholding (F) | Common Stock | 659 | USD 61.58 | USD 40,581 | SEC filing ↗ |
| 2026-09-02 | Cowan Elvia | Tax withholding (F) | Common Stock | 326 | USD 61.58 | USD 20,075 | SEC filing ↗ |
| 2026-09-01 | Wassil Jim | Sale (S) | Common Stock | 3,477 | USD 61.08 | USD 212,360 | SEC filing ↗ |
| 2026-09-01 | Wassil Jim | Option exercise / conversion (M) | Common Stock | 2,250 | USD 5.35 | USD 12,038 | SEC filing ↗ |
| 2026-08-31 | Wassil Jim | Tax withholding (F) | Common Stock | 1,273 | USD 60.74 | USD 77,322 | SEC filing ↗ |
| 2026-08-31 | PICKERING GRANT | Tax withholding (F) | Common Stock | 2,862 | USD 60.74 | USD 173,838 | SEC filing ↗ |
| 2026-08-31 | GUGGENHIME ANDREW | Tax withholding (F) | Common Stock | 1,273 | USD 60.74 | USD 77,322 | SEC filing ↗ |
| 2026-08-31 | Dhaliwal Harpreet S. | Tax withholding (F) | Common Stock | 361 | USD 60.74 | USD 21,927 | SEC filing ↗ |
| 2026-08-31 | Cowan Elvia | Tax withholding (F) | Common Stock | 243 | USD 60.74 | USD 14,760 | SEC filing ↗ |
| 2026-08-05 | Dhaliwal Harpreet S. | Sale (S) | Common Stock | 17,000 | USD 55.00 | USD 935,000 | SEC filing ↗ |
| 2026-08-05 | Dhaliwal Harpreet S. | Option exercise / conversion (M) | Common Stock | 17,000 | USD 24.79 | USD 421,430 | SEC filing ↗ |
| 2026-08-03 | Wassil Jim | Sale (S) | Common Stock | 2,250 | USD 53.86 | USD 121,195 | SEC filing ↗ |
| 2026-08-03 | Wassil Jim | Option exercise / conversion (M) | Common Stock | 2,250 | USD 5.35 | USD 12,038 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | PCVX |
| CIK | 0001649094 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 929 transaction lines from 2020-06-16 to 2026-10-05 4 P purchase lines · 554 S sale lines · 371 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.